Atovaquonestructure (Atovaquonestructure)
Chemical structure of Atovaquone, one of the active ingredients in Atovaquone and Proguanil Hydrochloride tablets.*
Atovaquone And Proguanil Hydrochloride Tablet, Film Coated
Product Images NDC 71335-3160
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atovaquone And Proguanil Hydrochloride (NDC 71335-3160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl713353160)
Label for Atovaquone and Proguanil Hydrochloride Tablets 250 mg/100 mg, film-coated oral tablets. The package contains 10 tablets. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Glenmark Pharmaceuticals Limited. Storage instructions and usage cautions are also shown, including temperature guidelines and safety seal information. The NDC is 71335-3160-1.*
Logo (Logo)
Proguanilstructure (Proguanilstructure)
Chemical structure of Atovaquone and Proguanil Hydrochloride, illustrating the molecular arrangement including a chlorinated phenyl ring and associated functional groups with hydrochloride (HCl).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
